BRPI0913753A2 - composição e uso de um gel bioadesivo endoparasiticida oral de ação prolongada a base de doramectina - Google Patents

composição e uso de um gel bioadesivo endoparasiticida oral de ação prolongada a base de doramectina

Info

Publication number
BRPI0913753A2
BRPI0913753A2 BRPI0913753A BRPI0913753A BRPI0913753A2 BR PI0913753 A2 BRPI0913753 A2 BR PI0913753A2 BR PI0913753 A BRPI0913753 A BR PI0913753A BR PI0913753 A BRPI0913753 A BR PI0913753A BR PI0913753 A2 BRPI0913753 A2 BR PI0913753A2
Authority
BR
Brazil
Prior art keywords
endoparasiticide
doramectin
composition
long
gel based
Prior art date
Application number
BRPI0913753A
Other languages
English (en)
Inventor
Edgar Régulo Vega Carrasco
Jorge Fabián Ruiz Herrera
José Fernando Tang Ploog
Umberto Calderon Ojeda
Original Assignee
Agrovet Market S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agrovet Market S A filed Critical Agrovet Market S A
Publication of BRPI0913753A2 publication Critical patent/BRPI0913753A2/pt
Publication of BRPI0913753B1 publication Critical patent/BRPI0913753B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
BRPI0913753A 2008-09-19 2009-08-28 composição e uso de um gel bioadesivo endoparasiticida oral de ação prolongada a base de doramectina BRPI0913753B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PE0015512008 2008-09-19
PCT/IB2009/006867 WO2010032113A2 (es) 2008-09-19 2009-08-28 Composición y uso de un gel oral endoparasiticida bioadhesivo de larga acción a base de doramectina

Publications (2)

Publication Number Publication Date
BRPI0913753A2 true BRPI0913753A2 (pt) 2015-10-20
BRPI0913753B1 BRPI0913753B1 (pt) 2018-07-17

Family

ID=42039956

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913753A BRPI0913753B1 (pt) 2008-09-19 2009-08-28 composição e uso de um gel bioadesivo endoparasiticida oral de ação prolongada a base de doramectina

Country Status (12)

Country Link
US (1) US8455452B2 (pt)
EP (1) EP2345413A4 (pt)
CN (1) CN102202671A (pt)
AU (1) AU2009294293A1 (pt)
BR (1) BRPI0913753B1 (pt)
CA (1) CA2737671A1 (pt)
CR (1) CR20110207A (pt)
EA (1) EA022209B1 (pt)
MX (1) MX2009001235A (pt)
PE (1) PE20100713A1 (pt)
WO (1) WO2010032113A2 (pt)
ZA (1) ZA201102793B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104168886A (zh) * 2012-03-13 2014-11-26 拜耳新西兰有限公司 长效组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN933396A0 (en) 1996-04-17 1996-05-09 Pfizer Pty Limited Non-aqueuos oral-drench compositions containing avermectin compounds
EP0959891A1 (en) 1996-07-30 1999-12-01 Ashmont Holdings Limited Anthelmintic formulations
GB9827727D0 (en) * 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
US6893652B2 (en) * 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
DK1435786T3 (da) * 2001-09-17 2011-10-03 Lilly Co Eli Pesticide formuleringer
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations

Also Published As

Publication number Publication date
AU2009294293A1 (en) 2010-03-25
CN102202671A (zh) 2011-09-28
WO2010032113A2 (es) 2010-03-25
CA2737671A1 (en) 2010-03-25
MX2009001235A (es) 2010-04-29
US20110160155A1 (en) 2011-06-30
WO2010032113A3 (es) 2010-06-17
ZA201102793B (en) 2011-12-28
EP2345413A4 (en) 2013-11-20
BRPI0913753B1 (pt) 2018-07-17
EA022209B1 (ru) 2015-11-30
PE20100713A1 (es) 2010-10-13
CR20110207A (es) 2011-09-06
US8455452B2 (en) 2013-06-04
EP2345413A2 (en) 2011-07-20
EA201170470A1 (ru) 2011-10-31

Similar Documents

Publication Publication Date Title
SMT201500210B (it) Composizioni applicazioni di gel rimovibili per unghie e metodi per il loro uso
BRPI0916769A2 (pt) derivados de benzilbenzeno deuterados e métodos de uso
DK1763673T3 (da) Anvendelser af gelformuleringer
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BRPI0821165A2 (pt) Uso de uma composição
BRPI0810696A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0919942A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0613033A2 (pt) composição oral
BRPI0908792A2 (pt) Composição, e, uso de uma combinação
BRPI0906186A2 (pt) composto e uso de um composto
BRPI0917579A2 (pt) composto, composição farmacêutica, métodos, e, uso de um composto
HK1201720A1 (en) Refrigerator-temperature stable influenza vaccine compositions
BRPI0921879A2 (pt) composto, composição farmacêutica , e, uso de um composto
HN2007000437A (es) Compuestos de pirazolina y su uso y composiciones farmaceuticas
DK1794596T3 (da) Nye stabile lipidstandarder
ATE524529T1 (de) Neuartige gelbeschichtungsformulierung
BRPI0812159A2 (pt) inibidores de csf-1r, composições e métodos de uso
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI0810019A2 (pt) Composto, composição farmacêutica, e, uso de um composto
BRPI0906937A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0716698A2 (pt) Composto, composição farmacêutica e uso de um composto
BRPI0404605B1 (pt) Formulação de gasolina de aviação
BRPI0915473A2 (pt) composto, composição farmacêutica, e, uso de um composto

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2595 DE 29-09-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.